Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells

Cancer Research

Volumn 59, Issue 3, 1999, Pages 639-644

  Izbicka, Elzbieta ^a   Wheelhouse, Richard T ^c,d   Raymond, Eric ^a   Davidson, Karen K ^b   Lawrence, Richard A ^a   Sun, Daekyu ^a   Windle, Bradford E ^a   Hurley, Laurence H ^c   Von Hoff, Daniel D ^a  

^a CTRC Institute for Drug Development   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PORPHYRIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CYTOPATHOGENIC EFFECT; DRUG DNA INTERACTION; DRUG EFFECT; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TELOMERE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CATIONS; CELL NUCLEUS; DNA; DNA, NEOPLASM; ENZYME INHIBITORS; FEMALE; FIBROBLASTS; HELA CELLS; HUMANS; MODELS, MOLECULAR; NEOPLASMS; PORPHYRINS; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0033083378     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kim, N. W., Piatyszek, A. M., Prowse, K. R., Harley, C.B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011-2015, 1994.
2. Morin, G. Is telomerase a universal cancer target? J. Natl. Cancer Inst., 87: 859-861, 1995.
3. Raymond, E., Sun, D., Chen, S-F., Windle, B., and Von Hoff, D. Agents that target telomerase and telomeres. Curr. Opin. Biotech., 7: 583-591, 1996.
4. Parkinson, E. K. Do telomerase antagonists represent a novel anti-cancer strategy? Br. J. Cancer. 73: 1-4, 1996.
5. Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., and Cech, T. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science (Washington DC), 276: 561-567, 1997.
6. Weinrich, S., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V., Holt, S., Bodnar, A., Lichtsteiner, S., Kim, N., Trager, J., Taylor, R., Carlos, R., WH, Andrews, Wright, W., Shay, J., Harley, C., and Morin, G. Reconstitution of human telomerase with the template RNA component hTR and the catalytic subunit hTRT. Nat. Genet., 17: 498-502, 1997.
7. Nakayama, J., Tahara, H., Tahara, E., Saito, M., Ito, K., Nakamura, H., Nakanishi, T., Tahara, E., Ide, T., and Ishikawa, F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet., 17: 65-68, 1998.
8. Norton, J. C., Piatyszek, M. A., Wright, W. E., Shay, J. W., and Corey, D. R. Inhibition of human telomerase activity by peptide nucleic acids, Nat. Biotechnol., 14: 615-619, 1996.
9. Mata, J. E., Joshi, S. S., Paten, B., Pirruccello, S. J., Jackson, J. D., Elias, N., Paige, T. J., Medlin, K. L., and Iveson, P. L. A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicol. Appl. Pharmacol., 144: 189-197, 1997.
10. Strahl, K., and Blackburn, E. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human tumor cell lines. Mol. Cell. Biol., 16: 53-65. 1996.
11. Fletcher, T., Salazar, M., and Chen, S. Human telomerase inhibition by 7-deaza-2′-deoxypurine nucleoside triphosphates, Biochemistry, 35: 15611-15617, 1996.
12. Burger, A., Double, J., and Newell, D. Inhibition of telomerase activity in human testicular cancer cells. Eur. J. Cancer, 33: 638-644, 1997.
13. Blackburn, E. Structure and function of telomeres. Nature (Lond.), 350: 569-573, 1991.
14. Zahler, A. M., Williamson, J. R., Cech, T. R., and Prescott, D. M. Inhibition of telomerase by G-quartet structures. Nature (Lond.), 350: 718-720, 1991.
15. Salazar, M., Thompson, B. D., Kerwin, S. M., and Hurley, L. H. Thermally induced DNA/RNA hybrid to G-quadruplex transitions. Possible implications for telomere synthesis by telomerase. Biochemistry, 35: 16011-16115, 1996.
16. 3] G-tetraplex. Structure, 1: 263-282, 1993.
17. Mossman, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
18. Chen, S. F., Behrens, D. L., Behrens, C. H., Czerniak, P. M., Dexter, D. L., Dusak, B. A., Fredericks, J. R., Gale, K. C., Gross, J. L., Jiang, J. B., Kirshenbaum, M. R., McRipley, R. J., Papp, L. M., Patten, A. D., Perrella, F. W., Seitz, S. P., Stafford, M. P., Sun, J-H., Sun, T., Wuonola, M. A., and Von Hoff, D. D. XB596, a promising bis-naphthalimide anticancer agent. Anti-Cancer Drugs, 4: 447-457, 1993.
19. Lipscomb, L. A., Zou, F. X., Presnell, S. R., Woo, R. J., Peek, M. E., Plaskon, R., and Williams, L. D. Structure of a DNA-porphyrin complex. Biochemistry, 35: 2818-2823, 1996.
20. Zhu, X., Kumar, R., Mandal, M., Sharma, N., Sharma, H., Dhingra, U., Sokoloski, J., Hsiao, R., and Narayan, R. Cell cycle-dependent modulation of telomerase activity in tumor cells Proc. Natl. Acad. Sci. USA, 93: 6091-6095, 1996.
21. Holt, S., Aisner, D., Shay, J., and Wright, W. Lack of cell cycle regulation of telomerase activity in human cells. Proc. Natl. Acad. Sci. USA, 94: 10687-10692, 1997.
22. Lampidis, T., Bernal, S., Summerheys, I., and Chen, L. Selective toxicity of rhodamine 123 in carcinoma cells in vitro. Cancer Res., 43: 716-720, 1983.
23. Georgiou, G. N., Ahmet, M. T., Houlton, A., Silver, J., and Cherry, R. J. Measurement of the rate of uptake and subcellular localization of porphyrins in cells using fluorescence digital imaging microscopy. Photochem. Photobiol. 59: 419-422, 1994.
24. Kirk, K., Harmon, B., Reichardt, I., Sedat, J., and Blackburn, E. Block in anaphase chromosome separation caused by telomerase template mutation. Science (Washington DC), 275: 1478-1481, 1997.
25. van Steensel, B., Smogorzewska, A., and de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell, 92: 401-413, 1998.
26. Counter, C. M., Avillion, A. A., Le Feuvre, C. E., Stewart, N. C., Greider, C. W., Harley, C. B., and Baccetti, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921-1922, 1992.
27. Bryan, T., Engelzou, A., Dalla-Pozza, L., Dunham, M., and Reddel, R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med., 3: 1271-1274, 1997.
28. Blasco, M., Lee, H., Hande, P., Samper, E., Lansdorp, P., DePinho, R., and Greider, C. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell, 91: 25-34, 1997.
29. Lee, H., Blasco, M., Gottlieb, G., Horner, J., Greider, C. and DePinho, R. Essential role of mouse telomerase in highly proliferative organs. Nature (Lond.), 392: 569-574, 1998.